Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
暂无分享,去创建一个
F. Lynch | K. Coleman | L. Croen | V. Quinn | M. Lakoma | A. Owen-Smith | J. Madden | Vincent M. Yau | Yinge X. Qian | Donna Rusinak
[1] Z. Warren,et al. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. , 2014, Morbidity and mortality weekly report. Surveillance summaries.
[2] F. Lynch,et al. Health Services Utilization Among Children With and Without Autism Spectrum Disorders , 2016, Journal of autism and developmental disorders.
[3] R. Canitano. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders , 2015, Clinical neuropharmacology.
[4] Virginia P. Quinn,et al. Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records , 2015, Journal of Autism and Developmental Disorders.
[5] S. Levy,et al. Attention-Deficit/Hyperactivity Disorder and Substance Abuse , 2014, Pediatrics.
[6] Fang Zhang,et al. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study , 2014, BMJ : British Medical Journal.
[7] C. Newschaffer,et al. Does a claims diagnosis of autism mean a true case? , 2014, Autism : the international journal of research and practice.
[8] Z. Warren,et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 , 2018, Morbidity and mortality weekly report. Surveillance summaries.
[9] Christine Stewart,et al. Health Care Contacts in the Year Before Suicide Death , 2014, Journal of General Internal Medicine.
[10] H. Pincus,et al. Acceptance of insurance by psychiatrists and the implications for access to mental health care. , 2014, JAMA psychiatry.
[11] Robert B. Penfold,et al. Use of Antipsychotic Medications in Pediatric Populations: What do the Data Say? , 2013, Current Psychiatry Reports.
[12] C. Mazefsky,et al. The role of emotion regulation in autism spectrum disorder. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.
[13] Nila A. Sathe,et al. Medications for Adolescents and Young Adults With Autism Spectrum Disorders: A Systematic Review , 2012, Pediatrics.
[14] J. Karst,et al. Parent and Family Impact of Autism Spectrum Disorders: A Review and Proposed Model for Intervention Evaluation , 2012, Clinical child and family psychology review.
[15] M. Siegel,et al. Psychotropic Medications in Children with Autism Spectrum Disorders: A Systematic Review and Synthesis for Evidence-Based Practice , 2012, Journal of autism and developmental disorders.
[16] L. Ruta,et al. Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges , 2012, Annals of General Psychiatry.
[17] Zachary Warren,et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. , 2012, Archives of general psychiatry.
[18] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[19] Zachary Warren,et al. A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders , 2011, Pediatrics.
[20] C. Carter,et al. Autism Symptoms and Internalizing Psychopathology in Girls and Boys with Autism Spectrum Disorders , 2011, Journal of autism and developmental disorders.
[21] K. O'Connor,et al. Primary care pediatricians' satisfaction with subspecialty care, perceived supply, and barriers to care. , 2010, The Journal of pediatrics.
[22] D. Mandell,et al. Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008 , 2010, Journal of autism and developmental disorders.
[23] S. Hartley,et al. Sex Differences in Autism Spectrum Disorder: An Examination of Developmental Functioning, Autistic Symptoms, and Coexisting Behavior Problems in Toddlers , 2009, Journal of autism and developmental disorders.
[24] J. Greenberg,et al. A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders , 2009, Journal of autism and developmental disorders.
[25] G. Baird,et al. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.
[26] Aubyn C. Stahmer,et al. Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders , 2008, Pediatrics.
[27] C. Johnson,et al. Identification and Evaluation of Children With Autism Spectrum Disorders , 2007, Pediatrics.
[28] D. Oswald,et al. Medication use among children with autism spectrum disorders. , 2007, Journal of child and adolescent psychopharmacology.
[29] R. Canitano. Epilepsy in autism spectrum disorders , 2007, European Child & Adolescent Psychiatry.
[30] L. Lotspeich,et al. A Comparison of Health Care Utilization and Costs of Children With and Without Autism Spectrum Disorders in a Large Group-Model Health Plan , 2006, Pediatrics.
[31] C. Holzer,et al. The continuing shortage of child and adolescent psychiatrists. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[32] Adrian Angold,et al. 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: I. Methods and public health burden. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.
[33] M. Aman,et al. Prevalence and Patterns of Use of Psychoactive Medicines Among Individuals with Autism in the Autism Society of Ohio , 2003, Journal of autism and developmental disorders.
[34] R. Kessler,et al. Mood disorders in children and adolescents: an epidemiologic perspective , 2001, Biological Psychiatry.
[35] B. Leventhal,et al. The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.
[36] Jacob Cohen,et al. An epidemiological study of disorders in late childhood and adolescence--I. Age- and gender-specific prevalence. , 1993, Journal of child psychology and psychiatry, and allied disciplines.
[37] A. Couteur,et al. Autism diagnostic interview: A standardized investigator-based instrument , 1989, Journal of autism and developmental disorders.
[38] G. Dawson. Dramatic increase in autism prevalence parallels explosion of research into its biology and causes. , 2013, JAMA psychiatry.
[39] Sarah L. Logan,et al. High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. , 2012, Annals of epidemiology.
[40] Johnny L. Matson,et al. The increasing prevalence of autism spectrum disorders , 2011 .
[41] Hubert Korzilius,et al. A meta-analytic study on the effectiveness of comprehensive ABA-based early intervention programs for children with Autism Spectrum Disorders , 2011 .
[42] M. Glasser. The history of managed care and the role of the child and adolescent psychiatrist. , 2010, Child and Adolescent Psychiatric Clinics of North America.
[43] Joseph Biederman,et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. , 2002, The American journal of psychiatry.